THERE is a strong and significant
association between drug name
confusion error rates observed in
the real world and those observed
in laboratory-based tests of
memory and perception, a study
published in the British Medical
Journal has demonstrated.
The authors recommended
that drug regulators and sponsor
companies use these tests prior
to finalising or accepting names
of drugs to minimise the risk of
confusion and medication errors.The above article was sent to subscribers in Pharmacy Daily's issue from 25 May 16 To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 25 May 16
DEMENTIA Australia has appointed comedian Geraldine Hickey (pictured) as its newest Ambassador, coinciding with the Melbourne Memory Walk & Jog event taking place this Sun.
NEW research from the Monash Addiction Research Centre has highlighted a critical shortfall in the availability of Naloxone, a life-saving medication that reverses opioid overdoses, across community pharmacies in Australia’s most populous states.
FREE Pharmacy Daily subscription - never miss another story!
to top
Subscribe to Pharmacy Daily
Pharmacy Daily subscription confirmation
Thank you for signing up! Check your email inbox – you should shortly receive a message with a link which must be clicked to confirm your subscription.
Once you’ve done that you will begin receiving Pharmacy Daily as soon as the next issue is published.